<DOC>
	<DOCNO>NCT01159548</DOCNO>
	<brief_summary>There increase ambulatory surgical procedure perform across Canada ; ambulatory procedure account almost 70 % surgery . Postoperative nausea vomiting ( PONV ) pain frequently report adverse event patient prior discharge ambulatory surgery . The incidence high 70 80 % high-risk patient . PONV cause morbidity particularly gynecological procedure incidence patient experience PONV high 58-75 % . Apart delay recovery , occurrence PONV link gastric aspiration , psychological distress wound dehiscence . The occurrence PONV delay patient discharge lead cause unexpected admission ambulatory anesthesia Promethazine , antiemetic medication widely use last 50 year , although effective reduce PONV , tend cause sedation . In study , try determine small dose promethazine , addition standard treatment post-surgical nausea vomiting , beneficial standard treatment . It hypothesize use low dose promethazine ( 3 mg ) part multimodal antiemetic regimen efficacious prevent PONV without sedative effect promethazine .</brief_summary>
	<brief_title>Efficacy Low Dose Promethazine Postoperative Nausea Vomiting</brief_title>
	<detailed_description />
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Promethazine</mesh_term>
	<mesh_term>Diphenhydramine</mesh_term>
	<criteria>1 . Patient 18 60 yr age 2 Patient 's health grade class IIII accord American Society Anesthesiologists physical status classification . 3 . The patient 2 follow risk factor : Female Nonsmoker History PONV/motion sickness Use postoperative opioids ( current surgery ) 4 . Undergoing ambulatory gynecological laparoscopic procedure least 30 minute duration preexist nausea , vomit retching , gastric outlet intestinal obstruction clinical evidence difficult airway obesity ( body mass index &gt; 40 kg m2 ) schedule receive propofol anesthesia maintenance current pregnancy psychiatric illness clinically significant major organic disease preoperative QTc interval &gt; 440 ms electrocardiogram know hypersensitivity promethazine , granisetron , ondansetron 5 HT3receptor antagonist</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>